Endogenous Protease-Activatable Nanosensor Based on PNA–Peptide–DNA Engineering for AND-Gated and Dual-Model Detection of MicroRNA in Single Living Tumor Cells
ACS Applied Materials & Interfaces · 2023
DOI: 10.1021/acsami.3c02012 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, 2023. Written by Xiaoxue Xi and 6 co-authors. Institution: Collaborative Innovation Center for Advanced Organic Chemical Materials, Coconstruted by the Province and Ministry of Education Key Laboratory for th…. Major MEDLINE topics: MicroRNAs, Peptide Nucleic Acids, Neoplasms. Cited 9 times so far (Crossref); 41 references. Funded by: National Natural Science Foundation of China.
Abstract (original language)
The in situ detection of low-content cancer biomarkers by an endogenous activator instead of an exogenous initiator in vitro remains a great challenge, leaving a gap in the development of a tumor-specific nanosensor with an endogenous protease-activatable manner. Herein, we proposed an endogenous protease-activatable nanosensor (PA-NS) guided by peptide nucleic acid-peptide-DNA copolymers to realize AND-gated and dual-model sensing of miRNA-21 (miR-21) by combining electrochemical detection with optical imaging in living tumor cells, without an additional introduction of an exogenous activator or nanomaterials. Moreover, the PA-NS can only be activated by "dual keys" (overexpressed miR-21 and cathepsin B protease in tumor cells) simultaneously, which enables effective improvement of the tumor-to-healthy cells ratio. The fluorescence intensity measured in single tumor cells was ∼3.5-fold higher than that in single healthy cells, and the electrochemical response decreased ∼30% in the presence of target miRNA. Furthermore, studies on regulation of the protease activity and miR-21 fluctuation under external stimulation have contributed to our understanding of the biological processes and drug screenings underlying disease development. This specific endogenous protease-mediated manner for dual-model detection of miRNA guarantees excellent tumor-selective capability, which offers new opportunities to study cell heterogeneity and provides more reliable fundamentals for the diagnosis and treatment of cancer down to the single-cell level.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Collaborative Innovation Center for Advanced Organic Chemical Materials, Coconstruted by the Province and Ministry of Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules, College o…
- Faculty of Physics and Electronic Sciences, Wuhan 430062, Hubei, P. R. China.
- Britton Chance Center for Biomedical Photonics at Wuhan National Laboratory for Optoelectronics-Hubei Bioformatics and Molecular Imaging Key Laboratory, Department of Biomedicine Engineering, College of Life Science and…
ORCID profiles: Xiuhua Zhang, Yuebin Li, Yuandi Zhao, Wei Wen, Shengfu Wang
Funding
- National Natural Science Foundation of China
Cite
APA
Xi, X., Wu, Z., Zhang, X., Li, Y., Zhao, Y., Wen, W., & Wang, S. (2023). Endogenous Protease-Activatable Nanosensor Based on PNA–Peptide–DNA Engineering for AND-Gated and Dual-Model Detection of MicroRNA in Single Living Tumor Cells. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c02012
Vancouver
Xi X, Wu Z, Zhang X, Li Y, Zhao Y, Wen W, et al. Endogenous Protease-Activatable Nanosensor Based on PNA–Peptide–DNA Engineering for AND-Gated and Dual-Model Detection of MicroRNA in Single Living Tumor Cells. ACS Applied Materials & Interfaces. 2023. doi:10.1021/acsami.3c02012
BibTeX
@article{Xi2023,
author = {Xi, Xiaoxue and Wu, Zhen and Zhang, Xiuhua and Li, Yuebin and Zhao, Yuandi and Wen, Wei and Wang, Shengfu},
title = {Endogenous Protease-Activatable Nanosensor Based on PNA–Peptide–DNA Engineering for AND-Gated and Dual-Model Detection of MicroRNA in Single Living Tumor Cells},
journal = {ACS Applied Materials & Interfaces},
year = {2023},
doi = {10.1021/acsami.3c02012}
}
EUVIMED